Achyut Healthcare Ltd
Incorporated in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company dealing in API, Pharmaceutical products, medical devices, etc.[1]
- Market Cap ₹ 86.4 Cr.
- Current Price ₹ 3.67
- High / Low ₹ 6.25 / 2.82
- Stock P/E 157
- Book Value ₹ 1.33
- Dividend Yield 0.00 %
- ROCE 2.26 %
- ROE 1.77 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.76 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 2.06% over last 3 years.
- Company has high debtors of 160 days.
- Promoter holding has decreased over last 3 years: -20.1%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
0.67 | 0.33 | 0.27 | 4.05 | 2.70 | 6.14 | 3.05 | |
0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 3.25 | |
Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.20 |
OPM % | 1.49% | 3.03% | 3.70% | -0.74% | -10.00% | 0.33% | -6.56% |
0.00 | 0.01 | 0.00 | 0.14 | 0.59 | 0.73 | 0.92 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
Profit before tax | 0.01 | 0.02 | 0.01 | 0.10 | 0.31 | 0.74 | 0.70 |
Tax % | 300.00% | 0.00% | 0.00% | 60.00% | 25.81% | 22.97% | 22.86% |
-0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.57 | 0.55 | |
EPS in Rs | -0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.02 | 0.02 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 56% |
3 Years: | -9% |
TTM: | -50% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 123% |
3 Years: | 140% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 57% |
1 Year: | -5% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 23.56 |
Reserves | -0.05 | -0.04 | 0.00 | 2.34 | 5.18 | 13.93 | 7.74 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 1.29 | |
Total Liabilities | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 |
0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.06 | 0.03 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 3.49 | 9.16 | 18.19 |
Investments | 0.00 | 0.00 | 0.00 | 1.70 | 1.30 | 0.00 | 0.00 |
0.24 | 0.27 | 0.50 | 8.21 | 10.50 | 21.73 | 14.37 | |
Total Assets | 0.24 | 0.27 | 0.50 | 9.94 | 15.34 | 30.95 | 32.59 |
Cash Flows
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
-0.03 | -0.02 | 0.01 | -6.96 | -0.43 | -0.36 | -4.06 | |
0.00 | 0.00 | 0.00 | -1.60 | -4.81 | -15.23 | 4.69 | |
0.00 | 0.00 | 0.00 | 8.79 | 5.21 | 15.72 | 0.00 | |
Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 | 0.14 | 0.62 |
Ratios
Figures in Rs. Crores
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|
Debtor Days | 54.48 | 188.03 | 378.52 | 18.02 | 36.50 | 24.37 | 160.36 |
Inventory Days | 0.00 | 0.00 | 158.70 | 14.29 | 59.59 | 3.96 | 24.16 |
Days Payable | 380.87 | 41.78 | 55.87 | 9.24 | 143.71 | ||
Cash Conversion Cycle | 54.48 | 188.03 | 156.34 | -9.46 | 40.22 | 19.09 | 40.81 |
Working Capital Days | 76.27 | 210.15 | 216.30 | 603.83 | 1,257.22 | 1,242.43 | 1,169.20 |
ROCE % | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% | 2.26% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
-
Appointment of Company Secretary and Compliance Officer
5 Jun - Appointment of Kaushalkumar Dave as Company Secretary & Compliance Officer on 05/06/2025.
-
Board Meeting Outcome for OUTCOME OF Board MEETING
5 Jun - Appointed Kaushalkumar Dave as Company Secretary and Compliance Officer effective June 5, 2025.
-
Submission Of Statement Of Deviation Or Variation For Proceeds Of Public Issue Pursuant To Regulation 32 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended On 31St March, 2025
29 May - No deviation in use of Rs. 2453.16 Lakhs public/preferential issue proceeds till 31 Mar 2025.
-
Appointment Of M/S. Mohta Khetawat & Co. Chartered Accountant As A Inetrnal Auditor For The One Year And M/S. Kamlesh M. Shah & Co. Company Secretaries As A Secretarial Auditor For A Period Of Five Years.
29 May - Approved audited FY25 results; net profit Rs.54.77L; appointed internal and secretarial auditors; no fund usage deviation.
Business Overview:[1]
Company is in the manufacturing of
pharmaceutical formulations in the
forms of Tablets, Capsules, Oral liquid
and Injectables.